Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk

Pancreatic ductal adenocarcinoma (PDA) remains one of the most lethal tumor types, with extremely low survival rates due to late diagnosis and resistance to standard therapies. A more comprehensive understanding of the complexity of PDA pathobiology, and especially of the role of the tumor microenvi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Proc Natl Acad Sci U S A
Prif Awduron: Orozco, Carlos A., Martinez-Bosch, Neus, Guerrero, Pedro E., Vinaixa, Judith, Dalotto-Moreno, Tomás, Iglesias, Mar, Moreno, Mireia, Djurec, Magdolna, Poirier, Françoise, Gabius, Hans-Joachim, Fernandez-Zapico, Martin E., Hwang, Rosa F., Guerra, Carmen, Rabinovich, Gabriel A., Navarro, Pilar
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: National Academy of Sciences 2018
Pynciau:
PNAS Plus
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5910865/
https://ncbi.nlm.nih.gov/pubmed/29615514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1722434115
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg